REQUEST A DEMO
Total
USD $0.00
Search more companies

Terapia SA (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Terapia SA Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Established in 1921, Terapia is the largest generic pharmaceutical company in Romania with strong brands and a consistent track record of growth. Terapia SA has a large product portfolio and a robust distribution network, including the largest generic sales force in the country. On 8 June 2006, Ranbaxy Laboratories Ltd. announced the completion of acquisition by Ranbaxy Netherlands BV of 96.7% of Terapia SA. After this acquisition, the company was liquidated, saw the establishment of a new company with the trade name of Terapia Ranbaxy, keeping legal name of Terapia SA. Today company become a subsidiary of Sun Pharmaceutical Industries Ltd.

Headquarters
Strada Fabricii Nr. 124
CLUJ-NAPOCA; Cluj; Postal Code: 400632

Contact Details: Purchase the Terapia SA report to view the information.

Website: http://www.terapia.ro

Basic Information
Total Employees:
Purchase the Terapia SA report to view the information.
Outstanding Shares:
Purchase the Terapia SA report to view the information.
Registered Capital:
Purchase the Terapia SA report to view the information.
Financial Auditors:
Purchase the Terapia SA report to view the information.
Incorporation Date:
May 28, 2004
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
96.81%
Subsidiaries
Pharmaplant Biogalenica SRL
99.972%
Promedic SRL
99.66%
Terapia SA
95.35%
Company Performance
Financial values in the chart are available after Terapia SA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
20.52%
Total operating revenue
20.66%
Operating profit (EBIT)
21.8%
EBITDA
21.37%
Net Profit (Loss) for the Period
19.72%
Total assets
8.07%
Total equity
7.6%
Operating Profit Margin (ROS)
0.28%
Net Profit Margin
-0.16%
Return on Equity (ROE)
3.2%
Quick Ratio
0.11%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?